Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. News
  7. Summary
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
DJ
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
12/03Merck & Co. Said to Seek Japanese Regulatory Nod for COVID-19 Pill
MT
12/03Merck Applies for Covid Pill Approval in Japan, Nikkei Reports
DJ
12/03Tokyo stocks end higher on hopes for COVID-19 oral treatment drug
AQ
12/02U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
AQ
12/02Federal Court Of Appeal Dismisses Appeal, Upholds Strict Interpretation Of Patent Listi..
AQ
12/01Merck & Company's Supplemental Biologics License Application for Vaxneuvance Gets FDA P..
MT
12/01Merck Gets FDA Priority Review of Vaxneuvance Vaccine in Children
DJ
12/01U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
BU
12/01U.S. Food and Drug Administration Accepts for Priority Review the Supplemental Biologic..
CI
11/30US FDA Panel Recommends Merck & Co.'s COVID-19 Pill
MT
More most relevant news
All news about MERCK & CO., INC.
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
DJ
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill
MT
12/03Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
12/03Bristol-Myers Squibb's Supplemental Biologics License Application for Drug Co-Developed..
MT
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
12/03Nikkei 225 Gains 1% on Merck Covid-19 Drug Application
MT
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
More news
News in other languages on MERCK & CO., INC.
12/03Merck & Co schließt Liefervereinbarung mit Kanada für Covid-19-Medikament
12/03MERCK : examen prioritaire de la FDA pour le reblozyl
12/03Le Nikkei 225 gagne 1 % grâce à la demande d'homologation du médicament Covid-19 de Mer..
12/03Merck & Co. Merck chercherait à obtenir l'aval des autorités japonaises pour la pilule ..
12/02CORONA-BLOG/Spahn sichert Deutschland Covid-Medikament Lagevrio von Merck
12/01MÄRKTE USA/Erster Omikron-Fall in den USA belastet die Wall Street
12/01MÄRKTE USA/Erholung - Berg- und Talfahrt geht weiter
12/01MÄRKTE USA/Festere Kurse zum Start - Börsen spielen wieder Entspannung
12/01MÄRKTE USA/Achterbahnfahrt geht wieder nach oben
12/01MERCK : examen prioritaire de la FDA sur le Vaxneuvance
More news
Analyst Recommendations on MERCK & CO., INC.
11/30ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer...
11/29SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $105, Keeps Outperform Rati..
MT
11/29Morgan Stanley Adjusts Merck & Co.'s Price Target to $82 from $88, Keeps Equalweight Ra..
MT
11/29ANALYST RECOMMENDATIONS : Asos, Burberry, Greif, Merck, Mirion Technologies....
11/29Citigroup Cuts Merck & Co. to Neutral From Buy, Price Target to $85 From $105
MT
More recommendations
Press releases
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
More press releases
Analysis
Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Upcoming event on MERCK & CO., INC.
02/03/22FY 2021 Earnings Release
Upcoming sector events
01/25/22JOHNSON & JOHNSON : FY 2021 Earnings Release
02/01/22PFIZER, INC. : FY 2021 Earnings Release (Projected)
02/02/22NOVO NORDISK A/S : FY 2021 Earnings Release
02/03/22ELI LILLY AND COMPANY : FY 2021 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals